nandrolone has been researched along with Mental Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busardò, FP; Fineschi, V; Frati, P; Napoletano, S; Pinchi, E; Sanzo, MD; Zaami, S | 1 |
| Ahmed, MA; El-Awdan, SA | 1 |
| BORUP SVENDSEN, B | 1 |
| BOITTELLE, G; BOITTELLE-LENTULO, C; DUMEZIL, C | 1 |
| Bjerstaf, L; Bjurwill, B; Ekman, B; Haeger, K; Ordell, R | 1 |
1 review(s) available for nandrolone and Mental Disorders
| Article | Year |
|---|---|
The impact of nandrolone decanoate on the central nervous system.
Topics: Anabolic Agents; Animals; Central Nervous System; Central Nervous System Diseases; Humans; Mental Disorders; Nandrolone; Nandrolone Decanoate | 2015 |
4 other study(ies) available for nandrolone and Mental Disorders
| Article | Year |
|---|---|
Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.
Topics: Acetylcholine; Animals; Antioxidants; Brain; Down-Regulation; Heme Oxygenase-1; Male; Mental Disorders; Nandrolone; Nandrolone Decanoate; Neuroprotective Agents; Neurotransmitter Agents; NF-E2-Related Factor 2; Oxidative Stress; Pentoxifylline; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Thioctic Acid; Up-Regulation | 2015 |
[Nortestosterone in urinary incontinence in senile demented women].
Topics: Dementia; Mental Disorders; Nandrolone; Psychotic Disorders; Testosterone; Urinary Incontinence; Urination Disorders | 1959 |
[Importance of norandrostenolone phenylpropionate in psychiatric therapy].
Topics: Counseling; Electroconvulsive Therapy; Humans; Mental Disorders; Nandrolone; Phenylpropionates; Psychosurgery; Psychotherapy; Testosterone | 1962 |
The effect on haematological and biochemical parameters by treatment with nortestosterone-3-(4-hexyloxyphenyl)-propionate.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Blood; Blood Proteins; Body Weight; Calcium; Chlorides; Creatinine; Depression, Chemical; Erythrocyte Count; Female; Hemoglobins; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Male; Mental Disorders; Middle Aged; Nandrolone; Nitrogen; Potassium; Propionates; Sodium; Stimulation, Chemical; Thymol; Urea; Vascular Diseases | 1970 |